Leap Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LPTX and other ETFs, options, and stocks.

About LPTX

Leap Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics. Its novel therapies are designed to treat patients with cancer.

CEO

Doug E. Onsi

CEODoug E. Onsi

Employees

Employees52

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2011

Founded2011

Employees

Employees52

LPTX Key Statistics

Market cap

20.22M

Market cap20.22M

Price-Earnings ratio

-0.31

Price-Earnings ratio-0.31

Dividend yield

—

Dividend yield—

Average volume

1.61M

Average volume1.61M

High today

$0.558

High today$0.558

Low today

$0.48

Low today$0.48

Open price

$0.51

Open price$0.51

Volume

742.74K

Volume742.74K

52 Week high

$4.79

52 Week high$4.79

52 Week low

$0.2223

52 Week low$0.2223

People also own

Based on the portfolios of people who own LPTX. This list is generated using Robinhood data, and it’s not a recommendation.